Subclinical Atrial Fibrillation and the Risk of Stroke (ASSERT trial)
JS Healey et al. N Engl J Med 2012;366:120-9.
Dr. Jorge Toquero
Read the rest of this entry »
Development and Validation of a Risk Score to Predict Early Mortality in Recipients of Implantable Cardioverter-Defibrillators
Kramer DB et al. Heart Rhythm 2012;9:42-46
Dr. Miguel A. Arias
Risk Stratification in Brugada Syndrome
Results of the PRELUDE (Programmed ELectrical stimUlation preDictive valuE) Registry
S Priori et al. J Am Coll Cardiol 2012;59:37–45
Dr. Jorge Toquero
Shocks Burden and Increased Mortality in Implantable Cardioverter-Defibrillator Patients
Larsen GK et al. Heart Rhythm 2011;08:1881-1886
Dr. Miguel A. Arias
Instantaneous Electrophysiological Changes Characterizing Achievement of Mitral Isthmus Linear Block
S Miyazaki et al. J Cardiovasc Electrophysiol,22:1217-1223
Dr. Jorge Toquero
Atrial Fibrillation Catheter Ablation Versus Surgical Ablation Treatment (FAST). A 2-Center Randomized Clinical Trial
Boersma LVA et al. Circulation 2011;125 : In Press
Dr. Miguel A. Arias
New Electrocardiographic Criteria for Discriminating Between Brugada Types 2 and 3 Patterns and Incomplete Right Bundle Branch Block
S Chevallier et al. J Am Coll Cardiol 2011;58:2290–8
Dr. Jorge Toquero
Postablation Asymptomatic Cerebral Lesions: Long-term Follow-up Using Magnetic Resonance Imaging
Deneke T et al. Heart Rhythm 2011;8:1705-1711
Dr. Miguel A. Arias
Management of Atrial Fibrillation Around the World: a Comparison of Current ACCF/AHA/HRS, CCS, and ESC Guidelines
K Wasmer and L Eckardt. Europace (2011);13:1368–1374
Dr. Jorge Toquero Read the rest of this entry »
Does Adenosine Response Predict Clinical Recurrence of Atrial Fibrillation after Pulmonary Vein Isolation?
LJ Gula et al. J Cardiovasc Electrophysiol;22:982-986
Dr. Jorge Toquero